Burg G - Search Results

1

Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma.

Heinzerling LM, Urbanek M, Funk JO, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P, Dummer R. Heinzerling LM, et al. Among authors: burg g. Cancer. 2000 Oct 15;89(8):1835-44. Cancer. 2000. PMID: 11042581 Clinical Trial.

2

Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma.

Heinzerling L, Dummer R, Kempf W, Schmid MH, Burg G. Heinzerling L, et al. Among authors: burg g. Arch Dermatol. 2000 Mar;136(3):374-8. doi: 10.1001/archderm.136.3.374. Arch Dermatol. 2000. PMID: 10724200

3

Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL).

Burg G, Dummer R. Burg G, et al. Clin Lymphoma. 2000 Nov;1 Suppl 1:S41-4. doi: 10.3816/clm.2000.s.008. Clin Lymphoma. 2000. PMID: 11707863 Review.

4

A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring.

Dummer R, Gore ME, Hancock BW, Guillou PJ, Grobben HC, Becker JC, Oskam R, Dieleman JP, Burg G. Dummer R, et al. Among authors: burg g. Cancer. 1995 Feb 15;75(4):1038-44. doi: 10.1002/1097-0142(19950215)75:4<1038::aid-cncr2820750421>3.0.co;2-f. Cancer. 1995. PMID: 7842406 Clinical Trial.

5

Classification of cutaneous lymphomas.

Burg G, Dummer R, Kerl H. Burg G, et al. Dermatol Clin. 1994 Apr;12(2):213-7. Dermatol Clin. 1994. PMID: 8045033 Review.

6

Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas.

Burg G, Schmid MH, Küng E, Dommann S, Dummer R. Burg G, et al. Dermatol Clin. 1994 Apr;12(2):399-407. Dermatol Clin. 1994. PMID: 8045051

7

Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study.

Dummer R, Krasovec M, Röger J, Sindermann H, Burg G. Dummer R, et al. Among authors: burg g. J Am Acad Dermatol. 1993 Dec;29(6):963-70. doi: 10.1016/0190-9622(93)70275-x. J Am Acad Dermatol. 1993. PMID: 8245262 Clinical Trial.

8

Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation.

Dummer R, Kohl O, Gillessen J, Kägi M, Burg G. Dummer R, et al. Among authors: burg g. Arch Dermatol. 1993 Apr;129(4):433-6. Arch Dermatol. 1993. PMID: 8466213

9

Soluble interleukin-2 receptors and cutaneous T-cell lymphoma.

Dummer R, Burg G, Nestle F, Kohl O. Dummer R, et al. Among authors: burg g. Cancer. 1993 Jun 1;71(11):3793-5. doi: 10.1002/1097-0142(19930601)71:11<3793::aid-cncr2820711153>3.0.co;2-c. Cancer. 1993. PMID: 8490933 No abstract available.

10

Pathology of cutaneous T-cell lymphoma.

Burg G, Dummer R, Dommann S, Nestle F, Nickoloff B. Burg G, et al. Hematol Oncol Clin North Am. 1995 Oct;9(5):961-95. Hematol Oncol Clin North Am. 1995. PMID: 8522491 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

651 results

Search Page

Filters